Acquired ALK and RET Gene Fusions as Mechanisms of Resistance to Osimertinib in EGFR-Mutant Lung Cancers.

ABSTRACT:

SUBMITTER: Offin M 

PROVIDER: S-EPMC6447364 | biostudies-literature | 2018

REPOSITORIES: biostudies-literature